Global Animal Auto-Immune Disease Diagnostics Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Test Type;

Complete Blood Count, Thyroid test, Biopsy Test, Urinalysis, DNA Amplification Test, and Immunoassays Test

By Indication;

Hypothyroidism, Pemphigus Disease, Canine Lupus, Auto-Immune Hemolytic Anemia, Bullous Pemphigoid, Discoid Lupus Erythematosus (DLE), Autoimmune hemolytic anemia, Immune-related arthritis, and Others

By Animal Type;

Companion Animal, Dogs, Cats, Horse, Live Stock Animal, Cattle, Swine, Poultry, Fish, and Sheep

By End User;

Veterinary Hospital and Veterinary Clinics

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn906506562 Published Date: June, 2025 Updated Date: July, 2025

Animal Auto-Immune Disease Diagnostics Market Overview

Animal Auto-Immune Disease Diagnostics Market (USD Million)

Animal Auto-Immune Disease Diagnostics Market was valued at USD 3,747.14 million in the year 2024. The size of this market is expected to increase to USD 4,955.60 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.1%.


Global Animal Auto-Immune Disease Diagnostics Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 4.1 %


Study Period2025 - 2031
Base Year2024
CAGR (%)4.1 %
Market Size (2024)USD 3,747.14 Million
Market Size (2031)USD 4,955.60 Million
Market ConcentrationHigh
Report Pages344
3,747.14
2024
4,955.60
2031

Major Players

  • IDEXX Laboratories, Inc
  • Zoetis Inc
  • Thermo Fisher Scientific Inc
  • Bio-Rad Laboratories, Inc
  • Neogen Corporation
  • Heska Corporation
  • Abaxis
  • Qiagen N.V
  • Virbac
  • IDvet

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Animal Auto-Immune Disease Diagnostics Market

Fragmented - Highly competitive market without dominant players


The Animal Auto-Immune Disease Diagnostics Market is expanding as veterinarians encounter rising cases of chronic immune disorders in animals. Conditions like lupus and autoimmune hemolytic anemia have seen a surge in detection, with case identification climbing by over 30%. This has led to growing reliance on accurate, early-stage diagnostics to improve treatment outcomes and animal welfare.

Higher Spending and Awareness Boosting Diagnosis Rates
Veterinary care spending is on the rise, with expenditures increasing by over 45%, as pet owners and farmers prioritize animal well-being. Greater awareness of autoimmune symptoms is prompting faster diagnosis, pushing the adoption of specialized testing technologies. This shift is encouraging clinics and labs to offer targeted immunological screening as part of routine care.

Veterinary R&D Driving Market Innovation
Ongoing investment in veterinary diagnostics R&D, particularly focused on immune disorders, accounts for over 40% of current innovation activity. The push toward faster, less-invasive, and more affordable diagnostic methods is shaping the market landscape. Companies are prioritizing the development of high-throughput assays and point-of-care devices for rapid results.

Cross-Sectoral Demand Fuels Growth
Both companion and farm animals are seeing increased diagnostic screening, with about 60% of clinics incorporating autoimmune testing into standard protocols. This demand stems from rising concerns over animal productivity, disease control, and improved pet care standards. The combined influence of healthcare demand and diagnostic advancements is strengthening market growth.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Test Type
    2. Market Snapshot, By Indication
    3. Market Snapshot, By Animal Type
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Animal Auto-Immune Disease Diagnostics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Technological advancements
        2. Increasing pet ownership
        3. Rising demand for diagnostics
        4. Growing awareness about animal health
      2. Restraints
        1. High cost of diagnostics
        2. Lack of skilled professionals
        3. Regulatory challenges
        4. Limited access in rural areas
      3. Opportunities
        1. Emerging markets expansion
        2. Development of point-of-care diagnostics
        3. Strategic collaborations and partnerships
        4. Focus on personalized medicine approaches
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Animal Auto-Immune Disease Diagnostics Market, By Test Type, 2021 - 2031 (USD Million)
      1. Complete Blood Count
      2. Thyroid test
      3. Biopsy Test
      4. Urinalysis
      5. DNA Amplification Test
      6. Immunoassays Test
    2. Animal Auto-Immune Disease Diagnostics Market, By Indication, 2021 - 2031 (USD Million)
      1. Hypothyroidism
      2. Pemphigus Disease
      3. Canine Lupus
      4. Auto-Immune Hemolytic Anemia
      5. Bullous Pemphigoid
      6. Discoid Lupus Erythematosus (DLE)
      7. Autoimmune hemolytic anemia
      8. Immune-related arthritis
      9. Others
    3. Animal Auto-Immune Disease Diagnostics Market, By Animal Type, 2021 - 2031 (USD Million)
      1. Companion Animal
      2. Dogs
      3. Cats
      4. Horse
      5. Live Stock Animal
      6. Cattle
      7. Swine
      8. Poultry
      9. Fish
      10. Sheep
    4. Animal Auto-Immune Disease Diagnostics Market, By End User, 2021 - 2031 (USD Million)
      1. Veterinary Hospital
      2. Veterinary Clinics
    5. Animal Auto-Immune Disease Diagnostics Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. IDEXX Laboratories, Inc
      2. Zoetis Inc
      3. Thermo Fisher Scientific Inc
      4. Bio-Rad Laboratories, Inc
      5. Neogen Corporation
      6. Heska Corporation
      7. Abaxis
      8. Qiagen N.V
      9. Virbac
      10. IDvet
  7. Analyst iew
  8. Future Outlook of the Market